APYX - Apyx Medical Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5 199.83M
Enterprise Value 3 116.53M
Trailing P/E 3.25
Forward P/E 1 -8.63
PEG Ratio (5 yr expected) 1 -0.56
Price/Sales (ttm) 10.46
Price/Book (mrq) 2.37
Enterprise Value/Revenue 3 6.10
Enterprise Value/EBITDA 6 -7.94

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq) Mar 31, 2019

Profitability

Profit Margin 315.32%
Operating Margin (ttm) -80.27%

Management Effectiveness

Return on Assets (ttm) -15.74%
Return on Equity (ttm) -21.58%

Income Statement

Revenue (ttm) 19.11M
Revenue Per Share (ttm) 0.57
Quarterly Revenue Growth (yoy) 71.40%
Gross Profit (ttm) 10.79M
EBITDA -14.68M
Net Income Avi to Common (ttm) -11.38M
Diluted EPS (ttm) 1.80
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 73.3M
Total Cash Per Share (mrq) 2.15
Total Debt (mrq) 215k
Total Debt/Equity (mrq) 0.26
Current Ratio (mrq) 11.40
Book Value Per Share (mrq) 2.48

Cash Flow Statement

Operating Cash Flow (ttm) -24.54M
Levered Free Cash Flow (ttm) -4.5M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.25
52-Week Change 3 ∞%
S&P500 52-Week Change 3 3.46%
52 Week High 3 8.89
52 Week Low 3 3.55
50-Day Moving Average 3 4.93
200-Day Moving Average 3 6.67

Share Statistics

Avg Vol (3 month) 3 360.71k
Avg Vol (10 day) 3 110.12k
Shares Outstanding 5 34.04M
Float 24.3M
% Held by Insiders 1 12.77%
% Held by Institutions 1 42.49%
Shares Short (Apr 30, 2019) 4 678.87k
Short Ratio (Apr 30, 2019) 4 1.07
Short % of Float (Apr 30, 2019) 4 2.06%
Short % of Shares Outstanding (Apr 30, 2019) 4 2.00%
Shares Short (prior month Mar 29, 2019) 4 342k

Dividends & Splits

Forward Annual Dividend Rate 4 N/A
Forward Annual Dividend Yield 4 N/A
Trailing Annual Dividend Rate 3 N/A
Trailing Annual Dividend Yield 3 N/A
5 Year Average Dividend Yield 4 N/A
Payout Ratio 4 0.00%
Dividend Date 3 N/A
Ex-Dividend Date 4 N/A
Last Split Factor (new per old) 2 N/A
Last Split Date 3 N/A